Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Liabilities (2020 - 2026)

Bioventus filings provide 6 years of Total Liabilities readings, the most recent being $455.1 million for Q4 2025.

  • On a quarterly basis, Total Liabilities fell 16.09% to $455.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $455.1 million, a 16.09% decrease, with the full-year FY2025 number at $455.1 million, down 16.09% from a year prior.
  • Total Liabilities hit $455.1 million in Q4 2025 for Bioventus, down from $494.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.0 billion in Q4 2022 to a low of $422.8 million in Q2 2021.
  • Median Total Liabilities over the past 5 years was $583.7 million (2023), compared with a mean of $596.3 million.
  • Biggest five-year swings in Total Liabilities: soared 401.34% in 2021 and later crashed 42.62% in 2023.
  • Bioventus' Total Liabilities stood at $618.2 million in 2021, then skyrocketed by 55.36% to $960.4 million in 2022, then crashed by 38.59% to $589.8 million in 2023, then fell by 8.04% to $542.4 million in 2024, then fell by 16.09% to $455.1 million in 2025.
  • The last three reported values for Total Liabilities were $455.1 million (Q4 2025), $494.3 million (Q3 2025), and $505.5 million (Q2 2025) per Business Quant data.